论文部分内容阅读
恶性肿瘤患者的血液流变学相关的指标明显要高于正常人群,因为恶性肿瘤细胞会释放出大量的成纤维类物质,这会激发机体的凝血系统,大大增加了不良事件的发生概率~([1])。当面对这类特殊的患者时,若首选化疗方案的话,须妥善考虑患者血液黏稠度的问题,以免局部血液黏滞增加化疗药物在局部的血药浓度,使血管壁细胞死亡~([2])。目前,以静脉作为化疗的给药途径方案有经外周静脉置入的中心静脉导管化疗以及外周静脉留置针化疗,而这2种干预方案在国内均有
Malignant tumor patients with hemorheology-related indicators were significantly higher than the normal population, because malignant tumor cells will release a large number of fibroblasts, which will stimulate the body’s coagulation system, greatly increased the probability of adverse events ~ ( [1]). When faced with this particular type of patient, if the preferred chemotherapy regimen, we must give due consideration to the patient’s blood viscosity problems, so as not to local blood viscosity increase chemotherapy drug local blood concentration, so that vascular cell death ~ ([2 ]). At present, the intravenous chemotherapy as the route of administration of the central venous catheter chemotherapy through the peripheral vein and peripheral venous catheterization chemotherapy, and the two kinds of intervention programs in the country have